- In March 2024, Medtronic plc, a global leader in medical technology, announced the launch of its next-generation antimicrobial external ventricular drain system designed to reduce catheter-associated infections (CAIs) in neurocritical care. The advanced EVD system features silver-impregnated catheters and enhanced flow regulation, reflecting Medtronic’s ongoing commitment to improving patient safety and outcomes in intensive care environments. This launch reinforces the company’s leadership in infection prevention and neurosurgical innovation
- In February 2024, Integra LifeSciences Holdings Corporation introduced a digital EVD monitoring platform in select European hospitals as part of a pilot program aimed at improving intracranial pressure management. This new system integrates real-time pressure readings and automated alerts to reduce human error and improve timely interventions. The pilot project represents a key step in digitizing neurocritical workflows and supports Integra's broader strategy to offer intelligent, data-driven solutions for neurosurgery
- In December 2023, Spiegelberg GmbH & Co. KG, a German manufacturer of neurosurgical devices, launched an enhanced ventricular drainage control unit with integrated safety valves and precise pressure adjustment capabilities. This upgrade is tailored for intensive care units with a focus on minimizing complications and improving drainage accuracy. Spiegelberg’s commitment to innovation and quality is further establishing its presence in European and Middle Eastern EVD markets
- In October 2023, Sophysa, a France-based medical device company specializing in neurosurgery, announced a collaboration with leading academic hospitals to evaluate the effectiveness of its programmable EVD systems in managing pediatric hydrocephalus. This partnership emphasizes the growing focus on customizable solutions for complex neurological conditions and positions Sophysa as a key player in the development of specialized drainage systems for vulnerable patient populations
- In August 2023, B. Braun Melsungen AG launched a clinical education campaign in Asia-Pacific to support the safe and standardized use of EVD systems in trauma and neurosurgical centers. The initiative includes hands-on training modules, digital resources, and regional partnerships with hospitals to improve clinical outcomes and infection control practices. This effort highlights B. Braun’s strategy of coupling product innovation with clinical support to expand its footprint in emerging neurocritical care markets
